| Followers | 200 |
| Posts | 25597 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Saturday, April 01, 2017 11:35:29 PM
Yonemura: Some of the key Yonemura case related docs:
https://drive.google.com/drive/folders/0B9XkDkpumQZSenJabEszUlJucnM?usp=sharing
These seem to be the most important and interesting docs. It seems like not much has happened and everyone is ready to settle. Also, they seem to have shared information, agreed to make some information in the original version of the second amended complaint from Yonemura confidential (it no longer exists), and to replace it with a new version of that complaint without certain confidential information. And then they spoke with counsel to the Special Committee and all agreed to defer things until that report, by Arnold & Porter, a very respected law firm. And now, the settlement details are being worked out. It seems done to me, unless something unexpected happens.
https://drive.google.com/drive/folders/0B9XkDkpumQZSenJabEszUlJucnM?usp=sharing
These seem to be the most important and interesting docs. It seems like not much has happened and everyone is ready to settle. Also, they seem to have shared information, agreed to make some information in the original version of the second amended complaint from Yonemura confidential (it no longer exists), and to replace it with a new version of that complaint without certain confidential information. And then they spoke with counsel to the Special Committee and all agreed to defer things until that report, by Arnold & Porter, a very respected law firm. And now, the settlement details are being worked out. It seems done to me, unless something unexpected happens.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
